Lataa...
Immunotherapy for pancreatic cancer
Pancreatic cancer, a highly lethal cancer, has the lowest 5-year survival rate for several reasons, including its tendency for the late diagnosis, a lack of serologic markers for screening, aggressive local invasion, its early metastatic dissemination, and its resistance to chemotherapy/radiotherapy...
Tallennettuna:
| Julkaisussa: | World J Clin Cases |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8080736/ https://ncbi.nlm.nih.gov/pubmed/33969083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v9.i13.2969 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|